Publicaciones en las que colabora con Miguel Angel Barajas Vélez (12)

2007

  1. Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature

    Biochemical and Biophysical Research Communications, Vol. 364, Núm. 1, pp. 92-99

2006

  1. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice

    Hepatology, Vol. 44, Núm. 3, pp. 623-632

2004

  1. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice

    Gut, Vol. 53, Núm. 4, pp. 561-567

2003

  1. In vitro and in vivo comparative study of chimeric liver-specific promoters

    Molecular Therapy, Vol. 7, Núm. 3, pp. 375-385

  2. Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosis

    Gene Therapy, Vol. 10, Núm. 13, pp. 1067-1078

2002

  1. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen

    Gene Therapy, Vol. 9, Núm. 23, pp. 1600-1606

2001

  1. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma

    Hepatology, Vol. 34, Núm. 1, pp. 72-81

  2. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

    Hepatology, Vol. 33, Núm. 1, pp. 52-61

  3. Gene therapy of primary and metastatic liver tumors.

    Medical science monitor : international medical journal of experimental and clinical research, Vol. 7 Suppl 1, pp. 76-77

2000

  1. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level

    Human Gene Therapy, Vol. 11, Núm. 1, pp. 113-125

  2. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

    Journal of Immunology, Vol. 164, Núm. 6, pp. 3112-3122

  3. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno- associated virus (rAAV): In vitro and in vivo effects of genotoxic agents

    Journal of Hepatology, Vol. 32, Núm. 6, pp. 975-985